Conference Menu
OverviewShort CoursesRegisterPDF DownloadDelegate ListPostersHotel & Travel Sponsorship & ExhibitsPress Pass Request Brochure
Corporate Sponsors
Media Partners
ImVacS brings together international vaccine leaders to discuss challenges and current breakthroughs in the world of vaccines. The four vaccine-focused meetings address innovating strategies to meet current health threats, changing technology for vaccine manufacture, top challenges faced during pre-clinical development, and progress underway for adjuvants and novel delivery systems. Altogether, ImVacS provides a snapshot of where vaccine development stands today in a collegial atmosphere that fosters information exchange, networking and establishing collaborations. We hope you will join the discussion aimed to advance vaccine science.
KEYNOTE PRESENTATIONS:
David Cho, Ph.D., M.P.H., Senior Scientist for Emerging and PandemicThreat Preparedness, Office of the Director, Center for Biologics Evaluation and Research (CBER), FDA
Norman Baylor, Ph.D., Director, Office of Vaccines Research and Review (OVRR), Center forBiologics Evaluation and Research (CBER), Food and Drug Administration, FDA
Jay Berzofsky, M.D., Ph.D., Chief, Vaccine Branch, Center for Cancer Research, National Cancer Institute (NCI), National Institutes of Health
George Siber, Ph.D., Director, Selecta Biosciences, and Executive Chairman, Genocea Biosciences
EVENT HIGHLIGHTS:
SHORT COURSES:Monday, August 16
Vaccines Business Opportunities Collaborations, Mergers And Acquisitions
Single-Use Systems (Disposables) For Vaccine Manufacture